Authors: SCHWARTSMANN G HOROWITZ M DILEONE L SANDER E CAMPOS O FERREIRA AF SCHUNEMANN H VIEGAS MAV CANCELA AI MANS DRA

Citation: G. Schwartsmann et al., PHASE-I TRIAL OF THE BOMBESIN RECEPTOR ANTAGONIST RC-3095 IN PATIENTSWITH REFRACTORY SOLID TUMORS, Annals of oncology, 9, 1998, pp. 651-651

Authors: SCHWARTSMANN G HOROWITZ M DILEONE L SANDER E CAMPOS O FERREIRA AF SCHUNEMANN H VIEGAS MAV CANCELA AI MANS DRA

Citation: G. Schwartsmann et al., PHASE-I TRIAL OF THE BOMBESIN RECEPTOR ANTAGONIST RC-3095 IN PATIENTSWITH REFRACTORY SOLID TUMORS, Annals of oncology, 9, 1998, pp. 420-420

Authors: MURAD AM GUIMARAES RC ARAGAO BC FERREIRA AF SCHWARTSMANN G BRUNDANI A

Citation: Am. Murad et al., PACLITAXEL(T) PLUS 5-FLUOROURACIL (5-FU) - A NOVEL AND VERY ACTIVE REGIMEN FOR ADVANCED GASTRIC-CANCER (AGC) - A PHASE-II TRIAL, European journal of cancer, 33, 1997, pp. 1255-1255

Authors: MANS DRA SCALETZKY A BECKER D DEOLIVEIRA JR PINHEIRO CM BITTAR C FERREIRA AF MACHADO VL RITT JL JUNG FA LEYVA A SCHWARTSMANN G

Citation: Dra. Mans et al., 2 NEW CASES OF HYPERPYRIMIDINURIA ASSOCIATED WITH EXCESSIVE 5-FLUOROURACIL TOXICITY, Annals of oncology, 5(8), 1994, pp. 772-773